Covid Treatments

• Canada enters 5th year of COVID-19. Are we falling short in treatment?

  As Canada enters its fifth year navigating COVID-19, treatment options for the virus remain disappointingly inadequate, according to advocates and experts.

  Health

  Dec 26, 2023
  
• U.S. to move COVID-19 vaccines, treatments to private market by 2023 once supply runs out

  President Joe Biden's administration expects to run out of federal funding for buying and distributing COVID-19 vaccines by January, officials said Tuesday.

  Health

  Aug 30, 2022
  
• Advertisement
• Canadian researchers discover ‘weak spot’ in COVID-19 virus key to treatments

  Researchers at the University of British Columbia have discovered what they are calling a `` weak spot'' in the virus that causes COVID-19.

  Health

  Aug 18, 2022
• Advertisement
• U.S. gives full approval to 1st COVID-19 drug for young children

  The U.S. drug regulator on Monday granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences Inc's GILD.O drug remdesivir.

  Health

  Apr 25, 2022
• UBC researchers say nasal spray could be the newest defense against COVID-19

  A nasal spray mechanism was found to be the most effective way to administer N-0385, Dr. François Jean said, as the virus tends to enter through the nasal passage.

  Health

  Mar 29, 2022
• Pfizer’s antiviral COVID-19 pill approved by U.K. regulators

  Pfizer this month said Paxlovid showed near 90 per cent efficacy in preventing hospitalizations and deaths in high-risk COVID-19 patients.

  World

  Dec 31, 2021
• Newly approved COVID-19 pills come with a catch. Here’s what you should know

  U.S. regulators authorized Pfizer's pill, Paxlovid, and Merck's molnupiravir this week.

  Health

  Dec 26, 2021
• Merck to make its COVID-19 antiviral pill in Canada, company announces

  Merck has reached an agreement with an Ontario pharmaceutical company to make its oral COVID-19 treatment, molnupiravir, in Canada, officials said Monday.

  Health

  Dec 6, 2021
• Advertisement
• Health Canada to review AstraZeneca’s COVID-19 prevention drug

  AstraZeneca has submitted its COVID-19 prevention drug to Health Canada for approval, which would make it the first antibody protection of its kind in Canada.

  Health

  Nov 3, 2021
• Advertisement
• AstraZeneca COVID-19 drug prevents severe disease if given early, company says

  The risk reduction was even better in patients who started therapy within just five days of initial symptoms, said company AstraZeneca.

  Health

  Oct 11, 2021